“…This has led to the establishment of recommendations on phased testing (e.g. WHO, 2014;NASEM, 2016;Hayes et al, 2018;James et al, 2018James et al, , 2020, the responsible and sustainable deployment of the technology (James et al, 2018(James et al, , 2020Warmbrod et al, 2020), and effective engagement of all concerned parties/stakeholders (Oye et al, 2014;Caplan et al, 2015;NASEM, 2016;Adelman et al, 2017a,b;Emerson et al, 2017;Najjar et al, 2017;James et al, 2018;Barnhill-Dilling et al, 2019;Bartumeus et al, 2019;Brossard et al, 2019;Buchthal et al, 2019;CSS-ENSSER-VDW, 2019;George et al, 2019;Hartley et al, 2019;Kofler, 2019;Kuzma, 2019;Rabitz, 2019;Singh, 2019;Thizy et al, 2019;Kelsey et al, 2020;Palmer et al, 2020;Serr et al, 2020;Warmbrod et al, 2020;WHO, 2020). Since some engineered gene drives may eventually spread across jurisdictional boundaries, regional approaches that would facilitate multi-country/international regulatory oversight and governance have been suggested (Marshall, 2010;Brown, 2017;James et al, 2018;Rabitz, 2019;Kelsey et al, 2020;Reynolds, 2020;Warmbrod et al, 2020).…”